Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Genome-Wide Analysis of BRD4-Targets Reveals the Therapeutic Relevance of Simultaneous Targeting of BCR Pathway and IKZF-MYC Axis in Mantle Cell Lymphoma

Junya Kuroda, MD PhD, Taku Tsukamoto, MD PhD, Shingo Nakahata, Kazuhiro Morishita, MD PhD, Ryuichi Sato, Akinori Kanai, PhD, Toshiya Inaba, Masakazu Nakano, Kei Tashiro, Masafumi Taniwaki, MD PhD

Blood (2018) 132 (Supplement 1): 4100.

https://doi.org/10.1182/blood-2018-99-109982

Published: 2018

Journal Articles

A New Prediction System for Platelet Recovery after Autologous Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphomas

Junko Yamaguchi, MD, Yoshiaki Chinen, MD PhD, Hitoji Uchiyama, MD PhD, Nobuhiko Uoshima, MD PhD, Hiroto Kaneko, MD PhD, Mitsushige Nakao, MD PhD, Taku Tsukamoto, MD PhD, Yuji Shimura, MD PhD, Tsutomu Kobayashi, MD PhD, Shigeo Horiike, MD PhD, Junya Kuroda, MD PhD

Blood (2018) 132 (Supplement 1): 2137.

https://doi.org/10.1182/blood-2018-99-112864

Published: 2018

Journal Articles

More Somatic Mutations Including Those in the Aid-Motif with High-Risk, Histologically Non-Transformed Follicular Lymphomas

Taku Tsukamoto, MD, Masakazu Nakano, PhD, Ryuichi Sato, Hiroko Adachi, Miki Kiyota, MD PhD, Satoru Yasukawa, MD PhD, Shotaro Tatekawa, MD, Yoshiaki Chinen, MD PhD, Hisao Nagoshi, MD PhD, Shinsuke Mizutani, MD PhD, Yuji Shimura, MD PhD, Mio Yamamoto-Sugitani, MD PhD, Tsutomu Kobayashi, MD PhD, Tomohiko Taki, MD PhD, Shigeo Horiike, MD PhD, Akio Yanagisawa, MD PhD, Masafumi Taniwaki, MD PhD, Kei Tashiro, MD PhD, Junya Kuroda, MD PhD

Blood (2016) 128 (22): 4116.

https://doi.org/10.1182/blood.V128.22.4116.4116

Published: 2016

Journal Articles

The Curative Potential Of Fludarabine125, Melphalan100, and Busulfan4 As a Conditioning Regimen For Myeloid Malignancies Of Elderly Patients

Tomoaki Ueda, MD, Aki Sato, M.D., Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Yusuke Okamoto, MD, Taku Tsukamoto, MD, Hiroyuki Sugiura, MD, Hiroyuki Matsui, MD, Tomoyasu Jo, MD, Kazuya Okada, MD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Akane Kunitomi, MD, PhD, Yasunori Ueda, MD, PhD

Blood (2013) 122 (21): 4551.

https://doi.org/10.1182/blood.V122.21.4551.4551

Published: 2013

Journal Articles

Pre-Treatment WT1 mRNA Expression Level In Peripheral Blood Predicts Response and Overall Survival Of Myelodysplastic Syndrome Patients In The Azacitidine Era

Tomoyasu Jo, MD, Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Yusuke Okamoto, MD, Taku Tsukamoto, MD, Hiroyuki Sugiura, MD, Hiroyuki Matsui, MD, Tomoaki Ueda, MD, Kazuya Okada, MD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Akane Kunitomi, MD, PhD, Yasunori Ueda, MD, PhD

Blood (2013) 122 (21): 1528.

https://doi.org/10.1182/blood.V122.21.1528.1528

Published: 2013

NARROW

Genome-Wide Analysis of BRD4-Targets Reveals the Therapeutic Relevance of Simultaneous Targeting of BCR Pathway and IKZF-MYC Axis in Mantle Cell Lymphoma

A New Prediction System for Platelet Recovery after Autologous Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphomas

More Somatic Mutations Including Those in the Aid-Motif with High-Risk, Histologically Non-Transformed Follicular Lymphomas

The Curative Potential Of Fludarabine125, Melphalan100, and Busulfan4 As a Conditioning Regimen For Myeloid Malignancies Of Elderly Patients

Pre-Treatment WT1 mRNA Expression Level In Peripheral Blood Predicts Response and Overall Survival Of Myelodysplastic Syndrome Patients In The Azacitidine Era

Email alerts

ASH Publications

American Society of Hematology

Genome-Wide Analysis of BRD4-Targets Reveals the Therapeutic Relevance of Simultaneous Targeting of BCR Pathway and IKZF-MYC Axis in Mantle Cell Lymphoma

A New Prediction System for Platelet Recovery after Autologous Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphomas

More Somatic Mutations Including Those in the Aid-Motif with High-Risk, Histologically Non-Transformed Follicular Lymphomas

The Curative Potential Of Fludarabine125, Melphalan100, and Busulfan4 As a Conditioning Regimen For Myeloid Malignancies Of Elderly Patients

Pre-Treatment WT1 mRNA Expression Level In Peripheral Blood Predicts Response and Overall Survival Of Myelodysplastic Syndrome Patients In The Azacitidine Era

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only